NASDAQ:EYEN
Delisted

Eyenovia Stock News

etoro logo Buy EYEN
*Your capital is at risk
$7.56
+0 (+0%)
At Close: Jan 16, 2026
Eyenovia, Inc. (EYEN) has been upgraded to a Zacks Rank 1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
NEW YORK, Nov. 13, 2019 -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its.
Canopy Growth (CGC) acquires a number of European companies to expand its production base across a region that promises great opportunities.
Applied Materials' (AMAT) technology leadership position and strong product line in Display and Services are likely to reflect on fiscal fourth-quarter results.
A series of acquisitions is expected to have significantly contributed to Canopy Growth's (CGC) top line in the fiscal second quarter.
Overstock's (OSTK) third-quarter results are likely to reflect strength across retail and blockchain businesses.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE